Comparison of Proton Pump Inhibitor and H2 Receptor Blocker on Prevention of Bleeding From Iatrogenic Ulcer After Endoscopic Submucosal Dissection for Gastric Neoplasms: A Prospective Randomized Controlled Trial
N/A
18 Years
80 Years
18 Years
80 Years
Open (Enrolling)
Both
Delayed Bleeding
Both
Delayed Bleeding
Trial Information
Comparison of Proton Pump Inhibitor and H2 Receptor Blocker on Prevention of Bleeding From Iatrogenic Ulcer After Endoscopic Submucosal Dissection for Gastric Neoplasms: A Prospective Randomized Controlled Trial
Inclusion Criteria:
- the patients who agreed informed consent
- gastric adenoma or early gastric cancer which is eligible for conventional ESD
indication
Exclusion Criteria:
- recent drug history of PPI, H2 rector antagonist, bismuth and antibiotics within 4
weeks
- recent drug history of anticoagulant or antiplatelet agent within 7 days
- s/p subtotal gastrectomy
- recurred gastric adenoma or cancer
- pregnant or breast feeding patients
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Prevention
Outcome Measure:
bleeding incidence after ESD
Outcome Time Frame:
time to occur delayed bleeding within one month after ESD
Safety Issue:
No
Authority:
South Korea: Institutional Review Board
Study ID:
2009-06-030
NCT ID:
NCT01179724
Start Date:
July 2009
Completion Date:
September 2010
Related Keywords:
- Delayed Bleeding
- Hemorrhage
- Stomach Neoplasms
Name | Location |
|---|
